ויגאם ליקוויד

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

IMMUNOGLOBULIN NORMAL HUMAN 5 %W/V

Disponible depuis:

KAMADA LTD

Code ATC:

J06BA02

forme pharmaceutique:

LIQUID

Mode d'administration:

I.V

Fabriqué par:

BIO PRODUCTS LABORATORY LIMITED (BPL), UK

Groupe thérapeutique:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

indications thérapeutiques:

Replacement therapy in: Primary immunodeficiency syndromes such as: congenital agammaglobulinaemia and hypogammaglobulinaemia common variable immunodeficiency severe combined immunodeficiency Wiskott Aldrich syndrome Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections. Children with congenital AIDS and recurrent infections. Immunomodulation: Idiopathic Thrombocytopenic Purpura (ITP) in children or adults at high risk of bleeding spontaneously or prior to surgery to correct the platelet count Guillain Barre Syndrome and Kawasaki disease. Allogeneic bone marrow transplantation.

Date de l'autorisation:

2010-12-01